Amplia CEO and MD, Dr Chris Burns, will be speaking at Bio Connections Australia in Melbourne on 31 July. Chris will join an important panel discussion about intellectual property (IP) and licensing of Australian technology.
Bio Connections Australia brings together a diverse mix of leading biotech industry stakeholders. This year’s event has an important focus on translation, drug development, and expediting Australia’s great science into commercialisation.
Find out more about BioConnections Australia.
